Press release
Bile Duct Cancer Market Ready to Hit at a CAGR of 9.2% by 2023 | Pfizer, F. Hoffmann-La Roche, Bristol-Myers Squibb, etc till 2023
Market Research Future published a research report on Global Bile Duct Cancer Market and Provide Market analysis, size, share and future growth of industry. The Global Bile Duct Cancer Market is expected to grow at an approximate CAGR of 9.1% during the forecast period. Report provide unique information which is unavailable on any other source and forecast up to 2023Bile duct cancer or cholangiocarcinoma is a rare form of cancer occurring due to uncontrolled growth of abnormal cells within the bile ducts, which can affect surrounding healthy tissues and organs like pancreas and can eventually spread to other areas in the body. Bile duct cancer can be diagnosed by imaging tests, blood test, abdominal ultrasound, biopsy of the affected tissue and other methods.
According to the American cancer society, 30,200 estimated deaths have occurred in U.S in 2017 and 42,220 new cases of intrahepatic bile duct cancer are expected to occur in U.S. in 2018 .The growing prevalence of bile duct cancer is likely to boost the market in forecast period.
The Global Bile Duct Cancer Market accounted to USD 154.5 million in 2017 and is forecasted to demonstrate a radial growth by 2018, Global Bile Duct market is expected to grow at a CAGR of 9.1% during forecasted period 2018-2023.
Get PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/4741 .
Key players for Global Bile Duct Cancer Market
The key players for the Global Bile Duct Cancer Market are Bristol-Myers Squibb Company (U.S.), F. Hoffmann-La Roche Ltd (Europe), Teva Pharmaceutical Industries Ltd.(Israel), Eli Lilly and Company(U.S.), Sanofi (France), Fresenius Kabi AG (Germany), Mylan N.V. (U.S.), Pfizer Inc.(US), Johnson & Johnson (U.S.), Celgene Corporation(U.S.) and others.
Competitive Landscape of Global Bile Duct Cancer Market
The Global Bile Duct Cancer Market appears to be highly fragmented and highly competitive due to new product launches and increasing clinical research. The key player have developed strategic approaches to increase their foothold in this market. The major key players are located in North America region like Pfizer Inc., Bristol-Myers Squibb Company increasing the market revenue in the region.
Pfizer Inc. is an American Global research based pharmaceutical company with its headquarter in New York City. Pfizer is engaged in developing, producing and manufacturing healthcare products. The major sector includes immunology, oncology, cardiology, endocrinology, and neurology. Pfizer Inc. has two business segments, Pfizer Innovative Health and Pfizer Essential Health. The company has its market in over 125 countries.
Eli Lilly and Company is a leading Global pharmaceutical corporation headquartered in Indiana, U.S. with its product sold in over 120 countries and manufacturing plants located in 17 countries. The company operates in two segments human pharmaceutical and animal healthcare. The human pharmaceutical segment includes immunology products, endocrinology products, neuroscience products, oncology products, and cardiovascular products. The Company's major oncology products include Altima, Cyramza, Gemzar, and Portrazza.
In March 2018, Eli Lilly and Company announced successful completion of its primary phase 3 REACH-2 trial study in trial biomarker selected population for CYRAMZA (ramucirumab), a single agent in the second-line treatment of people with hepatocellular carcinoma (HCC).The trial met its primary and secondary endpoint. This study proves beneficial for the company as CYRAMZA has demonstrated survival benefits in four regressive tumor type and as single agent in hepatocellular carcinoma.
Get an Exclusive Discount on Report @ https://www.marketresearchfuture.com/check-discount/4741 .
Segmentations for Global Bile Duct Cancer Market
The Global Bile Duct Cancer Market is segmented on the basis of types, diagnosis, treatment, and end users.
On the basis of types, the market is segmented into intrahepatic, extrahepatic, and others.
On the basis of diagnosis, the market is segmented into blood tests, abdominal imaging, surgery, and others. The diagnosis segment by abdominal imaging is sub segmented into endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), magnetic resonance cholangiopancreatography (MRCP), and others.
On the basis of treatment, the market is segmented into chemotherapy, radiotherapy, and others. The chemotherapy segment is sub segmented into 5-fluorouracil, gemcitabine, cisplatin, and others.
On the basis of end users, the market is segmented into hospital &clinics, academic institutes, research organizations and others.
Some Brief Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
TOC Continued…
LIST OF TABLES
Table 1 Bile Duct Cancer Industry Synopsis, 2017 – 2023
Table 2 Global Bile Duct Cancer Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Bile Duct Cancer Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Bile Duct Cancer Market By Types, 2017 – 2023, (USD Million)
Table 5 Global Bile Duct Cancer Market By Diagnosis, 2017 – 2023, (USD Million)
Table 6 Global Bile Duct Cancer Market By Treatment, 2017 – 2023, (USD Million)
Table 7 Global Bile Duct Cancer Market By End Users, 2017 – 2023, (USD Million)
Table 8 North America Bile Duct Cancer Market By Types, 2017 – 2023, (USD Million)
Continued…
Access Complete Report @ https://www.marketresearchfuture.com/reports/bile-duct-cancer-market-4741 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bile Duct Cancer Market Ready to Hit at a CAGR of 9.2% by 2023 | Pfizer, F. Hoffmann-La Roche, Bristol-Myers Squibb, etc till 2023 here
News-ID: 1064148 • Views: …
More Releases from Market Research Future

Two Healthcare Markets Poised for Strong Growth: AI in France and Global Fungal …
New market projections reveal two sectors within healthcare diagnostics and technology are set for rapid expansion: the France healthcare artificial intelligence (AI) market, expected to grow at a 17.04% CAGR to reach USD 11.17 billion by 2035, and the fungal testing kits market, forecasted to climb at a 9.08% CAGR to USD 25.73 billion by 2034. Both sectors are underpinned by demographic shifts, technological innovation, and heightened clinical awareness.
Download the…

Human Microbiome Modulator Market Set for Explosive Growth: Poised to Reach USD …
The global Human Microbiome Modulator market is experiencing a dramatic transformation. Recent forecasts from Market Research Future (MRFR) indicate that this industry is projected to surge from approximately USD 2.33 billion in 2025 to USD 13.37 billion by 2034, registering a robust Compound Annual Growth Rate (CAGR) of 21.44 percent over the nine-year forecast period.
Download the Sample PDF Brochure to Get Started - https://www.marketresearchfuture.com/sample_request/37124
Growing Awareness of Gut-Health Impact
Consumers and…

Pranlukast Market Expected to Hit USD 2.58 Billion by 2032 with a Remarkable 4.1 …
Pranlukast Market: Rising Demand for Anti-Asthmatic Therapies Drives Growth in Allergy Treatment Segment. The Pranlukast Market is gaining attention within the global pharmaceutical industry, especially as respiratory disorders like asthma and allergic rhinitis continue to affect millions of people worldwide. Pranlukast, a leukotriene receptor antagonist, is commonly prescribed as an anti-inflammatory agent to manage chronic asthma and seasonal allergies, particularly in pediatric and adult populations who are unresponsive to…

Healthcare Digital Twin Market Set to Reach USD 179.53 Billion, with a Healthy 3 …
Healthcare Digital Twin Market Overview:
Healthcare Digital Twin Market Research Report By Component (Software, Services, Hardware), By Deployment Model (On-premise, Cloud-based, Hybrid), By Application (Medical Device Development, Drug Discovery & Development, Clinical Trial Optimization, Personalized & Precision Medicine, Remote Patient Monitoring, Surgical Planning & Simulation, Hospital Management, Healthcare Research & Innovation), By End-use Industry (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Academic & Research Institutions) and By Regions…
More Releases for Bile
Bile Duct Cancer Drugs Market Demand by 2025: QY Research
This recently published report examines the global Bile Duct Cancer Drugs market for the projected period of 7-years, i.e. between 2018 and 2025. The report highlights the accomplishments and opportunities lies in the market throughout the forecasted period. The report offers the thorough information about the overview and the scope of the global Bile Duct Cancer Drugs market along with its drivers, restraints, and trends. It also classifies the market…
Bile Duct Cancer Drugs and Companies Research 2023
Report Description
This report analyzes the bile duct cancer market by type (intrahepatic, extrahepatic), diagnosis (blood tests, abdominal imaging, surgery), by treatment (chemotherapy, radiotherapy), by end user (hospital& clinics, academic institutes); it also studies the top manufacturers in the market.
The bile duct cancer market is expected to grow at a CAGR of near about 9.2% during the forecast period.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3439013-bile-duct-cancer-market-research-report-global-forecast-till-2023
The major players in bile duct cancer…
Cholangiocarcinoma (Bile Duct Cancer) Treatment Market worth US$ 144.2 Million
In 2017, the global market for bile duct cancer treatments is anticipated to bring in revenues worth a little over US$ 168 Mn. Apart from rising incidence of bile duct cancer across the APAC and Middle East & Africa region, increasing healthcare spending is also expected to drive the demand for bile duct cancer treatments. Towards the end of 2025, the global bile duct cancer treatment market is projected to…
Global Bile Duct Cancer Market is Driven by Increase in Prevalence of Bile Duct …
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing…
Bile Duct Cancer Market Overview and Report forecast 2025
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing…
Bile Duct Cancer Market Size – Industry Share Report 2025
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing…